Category: Peptides Research

I was skeptical when a colleague first slid a paper on Semax across the conference table. A synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone, developed in the Soviet Union in the 1980s, with a clinical history primarily documented in Russian-language literature — that’s not the kind of origin story that commands instant credibility…

Read more

There’s a peptide circulating in your bloodstream right now that peaks in your 20s and falls by roughly 60% by the time you reach 60. When I first came across that statistic in a pharmacology review, I stopped and re-read it twice. I’d spent years focused on neurological repair, growth factors, and cellular signaling —…

Read more

The first time a colleague handed me a paper on SS-31 peptide, I almost set it aside. A mitochondria-targeting tetrapeptide felt like fringe science — not the hard clinical data I’d built my career on. Then I read the mechanism. A compound that specifically partitions into the inner mitochondrial membrane, binds cardiolipin, and reduces oxidative…

Read more

I’ve sat across from patients who checked out fine on every scan we ran — no lesion, no bleed, no structural abnormality — and yet they couldn’t sleep, couldn’t focus, and lived in a low-grade state of dread they couldn’t quite name. That clinical gap haunts me. It’s part of why, a few years into…

Read more

Late one evening, I was reviewing post-stroke recovery literature — the kind of deep dive that starts at 11 PM and somehow becomes 2 AM. Most of what I read was familiar territory: standard neurological endpoints, predictable outcome measures. Then a study from the Institute of Molecular Genetics in Moscow stopped me cold. Researchers were…

Read more

Three amino acids. That’s it — lysine, proline, valine, strung together in a sequence so short you’d be forgiven for dismissing it as chemically insignificant. The first time I encountered KPV peptide research in the literature, I almost did exactly that. Then I read what this tripeptide does to NF-κB signaling in inflamed gut tissue,…

Read more

The human body already makes its own broad-spectrum antimicrobial compound. After years in neurosurgery — managing post-operative infections, watching the immune system either hold the line or fold under pressure — that fact still strikes me as remarkable. We pour billions into external antibiotics each year, yet one of the most powerful defense molecules was…

Read more

I’ve operated inside the human brain at 3 AM, when everything that could go wrong already has. In those quiet drives home afterward, the questions that stay with me aren’t about the surgery — they’re about why the body ages the way it does. Why do metabolic systems that worked flawlessly at 30 start failing…

Read more

I’ve watched more brains age than most people encounter in a lifetime. In the OR, I’ve seen the structural toll that years take on neural tissue — the shrinkage, the vascular changes, the slowing of repair processes that once happened quietly and efficiently. But one phenomenon keeps showing up in my research reading that I…

Read more

There’s a moment in every surgery when you’re reminded how incredibly precise the human body needs to be — and how quickly things fall apart when that precision fails. Immunosenescence — the gradual, inexorable decline of immune function with age — has fascinated me clinically for years. So when I came across the body of…

Read more